COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study.

Wang, Xuejun Alice; Binder, Adam F; Gergis, Usama; Wilde, Lindsay

Wang, Xuejun Alice; Binder, Adam F; Gergis, Usama; Wilde, Lindsay.

Afiliación

Wang XA; Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United States.
Binder AF; Department of Medical Oncology, Division of Hematologic Malignancies, Thomas Jefferson University Hospital, Philadelphia, PA, United States.
Gergis U; Department of Medical Oncology, Division of Hematologic Malignancies, Thomas Jefferson University Hospital, Philadelphia, PA, United States.
Wilde L; Department of Medical Oncology, Division of Hematologic Malignancies, Thomas Jefferson University Hospital, Philadelphia, PA, United States.

Front Oncol ; 11: 740320, 2021.

Article en En | MEDLINE | ID: mdl-34778057

Palabras clave

COVID-19; hematologic malignancy; leukemia; lymphoma; mortality; multiple myeloma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google